|
Originally published In Press as doi:10.1074/jbc.M112100200 on April 16, 2002
J. Biol. Chem., Vol. 277, Issue 26, 23800-23806, June 28, 2002
5'-,3'-Inverted Thymidine-modified Antisense Oligodeoxynucleotide
Targeting Midkine
ITS DESIGN AND APPLICATION FOR CANCER THERAPY*
Yoshifumi
Takei ,
Kenji
Kadomatsu ,
Hiroshi
Itoh§,
Waichi
Sato ,
Kunihiko
Nakazawa¶,
Shunichiro
Kubota¶, and
Takashi
Muramatsu
From the Department of Biochemistry, Nagoya
University School of Medicine, 65 Tsurumai-cho, Showa-ku,
Nagoya 466-8550, § Koken Bioscience Institute,
2-2-6 Okubo, Shinjuku-ku, Tokyo 169-0072, and the ¶ Department
of Physiological Chemistry and Metabolism, Graduate School of Medicine,
University of Tokyo, Tokyo 113-0033, Japan
Oligodeoxynucleotides modified at both 5'- and
3'-ends with inverted thymidine (5'-,3'-inverted T) were introduced as
new reagents for antisense strategies. These modifications were
performed to make the oligodeoxynucleotides resistant to nucleases. The effectiveness of these oligodeoxynucleotides was evaluated in terms of
inhibition of synthesis of midkine (MK), a heparin-binding growth
factor, and consequent inhibition of growth of CMT-93 mouse rectal
carcinoma cells. 5'-,3'-Inverted T antisense MK suppressed synthesis of
MK by CMT-93 cells and their growth in culture. Furthermore, 5'-,3'-inverted T oligodeoxynucleotides exhibited less cytotoxicity and
better stability than phosphorothioate oligodeoxynucleotides. When
5'-,3'-inverted T antisense MK was mixed with atelocollagen, and
injected into CMT-93 tumors pregrown in nude mice, tumor growth was
markedly suppressed as compared with tumors injected with sense
controls. The suppressive effect of 5'-,3'-inverted T antisense MK on
tumor growth was stronger than that of phosphorothioate antisense MK.
These findings indicated the usefulness of inverted thymidine-modified
antisense oligodeoxynucleotides as a new reagent instead of
phosphorothioate-modified oligodeoxynucleotides.
*
This work was supported in part by Grants-in-aid from the
Ministry of Education, Science, Sports and Culture of Japan 10CE2006 and from the Japan Society for the Promotion of Science 12004272.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Biochemistry, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Tel.: 81-52-7442059; Fax:
81-52-7442065; E-mail: tmurama@med.nagoya-u.ac.jp.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Takei, T. Nemoto, P. Mu, T. Fujishima, T. Ishimoto, Y. Hayakawa, Y. Yuzawa, S. Matsuo, T. Muramatsu, and K. Kadomatsu
In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency
Mol. Cancer Ther.,
January 1, 2008;
7(1):
211 - 221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chen, G. Bu, Y. Takei, K. Sakamoto, S. Ikematsu, T. Muramatsu, and K. Kadomatsu
Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells
J. Cell Sci.,
November 15, 2007;
120(22):
4009 - 4015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bhindi, R. G. Fahmy, H. C. Lowe, C. N. Chesterman, C. R. Dass, M. J. Cairns, E. G. Saravolac, L.-Q. Sun, and L. M. Khachigian
Brothers in Arms: DNA Enzymes, Short Interfering RNA, and the Emerging Wave of Small-Molecule Nucleic Acid-Based Gene-Silencing Strategies
Am. J. Pathol.,
October 1, 2007;
171(4):
1079 - 1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takei, K. Kadomatsu, Y. Yuzawa, S. Matsuo, and T. Muramatsu
A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics
Cancer Res.,
May 15, 2004;
64(10):
3365 - 3370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Kang, I.-J. Kim, J.-H. Park, Y. Shin, J.-L. Ku, M. S. Jung, B. C. Yoo, H. K. Kim, and J.-G. Park
Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide Microarrays
Clin. Cancer Res.,
January 1, 2004;
10(1):
272 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|